These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Therapeutic equivalency of generic antiepileptic drugs: results of a survey. Wilner AN. Epilepsy Behav; 2004 Dec; 5(6):995-8. PubMed ID: 15582850 [Abstract] [Full Text] [Related]
24. Myth: generic drugs are lower quality and less safe than brand-name drugs. Canadian Health Services Research Foundation. J Health Serv Res Policy; 2007 Oct; 12(4):255-6. PubMed ID: 17925080 [No Abstract] [Full Text] [Related]
25. [Generics as therapeutic resources]. Riverro-Serrano O, Juan-Lopez M, Lerdo-de Tejada F, Montoya-Cabrera MA, Camacho-Solís R, Valenzuela-Gomez Gallardo F, Lifshitz A, Gamboa-Marrufo J, Martínez-Domínguez M. Gac Med Mex; 1998 Oct; 134(2):169-206. PubMed ID: 9618996 [No Abstract] [Full Text] [Related]
27. Generic anticonvulsant use in children: do we have evidence to recommend brand formulations? Hamiwka LD. Arch Neurol; 2009 Nov; 66(11):1417-8. PubMed ID: 19901177 [No Abstract] [Full Text] [Related]
28. ACOG Committee Opinion No. 375: Brand versus generic oral contraceptives. Committee on Gynecologic Practice, American College of Obstetricians and GynecologistsAmerican College of Obstetricians and Gynecologists, 409 12th Street, Washington, DC 20090, USA.. Obstet Gynecol; 2007 Aug; 110(2 Pt 1):447-8. PubMed ID: 17666623 [Abstract] [Full Text] [Related]
29. Generics almost always a better choice. Johns Hopkins Med Lett Health After 50; 2009 Feb; 20(12):6-7. PubMed ID: 19241612 [No Abstract] [Full Text] [Related]
30. [Special generic drugs in Spain]. Carné X, Díez Rodrigálvarez M, García-Alonso F. Med Clin (Barc); 1999 Mar 13; 112(9):337-9. PubMed ID: 10220766 [No Abstract] [Full Text] [Related]
31. Questions & answers. I've been taking Zoloft. Recently, my pharmacist filled my prescription with a generic form of the drug. Does the brand name matter? Miller MC. Harv Ment Health Lett; 2007 Feb 13; 23(8):8. PubMed ID: 17340745 [No Abstract] [Full Text] [Related]
32. Comments on the note for guidance on bioavailability and bioequivalence in the European Union. Calvo G. Methods Find Exp Clin Pharmacol; 1998 Feb 13; 20 Suppl A():11. PubMed ID: 9800721 [No Abstract] [Full Text] [Related]
33. [The clinical and economic impact of generic drugs in the treatment of epilepsy]. Argumosa A, Herranz JL. Rev Neurol; 1998 Feb 13; 41(1):45-9. PubMed ID: 15999330 [Abstract] [Full Text] [Related]
34. [Access for all to quality drugs]. Videau JY. Med Trop (Mars); 2002 Feb 13; 62(4):396-400. PubMed ID: 12534178 [Abstract] [Full Text] [Related]
35. Recommendations concerning the introduction of generic formulations of cyclosporine. Kahan BD. Transplant Proc; 1999 May 13; 31(3):1634; discussion 1675-84. PubMed ID: 10331030 [No Abstract] [Full Text] [Related]
36. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy. Liow K, Barkley GL, Pollard JR, Harden CL, Bazil CW, American Academy of Neurology. Neurology; 2007 Apr 17; 68(16):1249-50. PubMed ID: 17438213 [No Abstract] [Full Text] [Related]
37. Impurities in generic pharmaceutical development. Kovaleski J, Kraut B, Mattiuz A, Giangiulio M, Brobst G, Cagno W, Kulkarni P, Rauch T. Adv Drug Deliv Rev; 2007 Jan 10; 59(1):56-63. PubMed ID: 17196702 [Abstract] [Full Text] [Related]
38. Bioequivalence and in vitro antimicrobial activity between generic and brand-name levofloxacin. Sun HY, Liao HW, Sheng MH, Tai HM, Kuo CH, Sheng WH. Diagn Microbiol Infect Dis; 2016 Jul 10; 85(3):347-351. PubMed ID: 27181716 [Abstract] [Full Text] [Related]
39. [Original or generic?]. Magyar IG. Neuropsychopharmacol Hung; 2005 Dec 10; 7(4):167-8. PubMed ID: 16496480 [No Abstract] [Full Text] [Related]
40. Polymorphism in generic drug product development. Snider DA, Addicks W, Owens W. Adv Drug Deliv Rev; 2004 Feb 23; 56(3):391-5. PubMed ID: 14962588 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]